Raluca Sosdean
Overview
Explore the profile of Raluca Sosdean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sosdean R, Danila M, Ionica L, Pescariu A, Mircea M, Ionac A, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408637
Monoamine oxidases (MAOs), mitochondrial enzymes that constantly produce hydrogen peroxide (HO) as a byproduct of their activity, have been recently acknowledged as contributors to oxidative stress in cardiometabolic pathologies. The...
2.
Braescu L, Sturza A, Sosdean R, Aburel O, Lazar M, Muntean D, et al.
Can J Physiol Pharmacol
. 2024 Sep;
102(11):648-660.
PMID: 39226407
This study aimed to assess the utility of echocardiography-measured epicardial adipose tissue (EAT) thickness (EATT) as an independent predictor for coronary artery disease (CAD), examining its correlation with oxidative stress...
3.
Ionica L, Buriman D, Linta A, Sosdean R, Lascu A, Streian C, et al.
Mol Cell Biochem
. 2024 Jul;
480(3):1645-1655.
PMID: 39042348
The sodium-glucose-cotransporter 2 inhibitors (SGLT2i) are the blockbuster antidiabetic drugs that exert cardiovascular protection via pleiotropic effects. We have previously demonstrated that empagliflozin decreased monoamine oxidase (MAO) expression and oxidative...
4.
Voinescu O, Ionac A, Sosdean R, Ionac I, Ana L, Kundnani N, et al.
Medicina (Kaunas)
. 2024 Apr;
60(4).
PMID: 38674189
: Cardiomyopathies (CMs) represent a heterogeneous group of primary myocardial diseases characterized by structural and functional abnormalities. They represent one of the leading causes of cardiac transplantations and cardiac death...
5.
Sosdean R, Lazar M, Pescariu S, Mircea M, Lala R, Mornos C, et al.
Life (Basel)
. 2024 Apr;
14(4).
PMID: 38672784
Lipomatous hypertrophy of the interatrial septum (LHIAS) represents a benign proliferation of lipoid cells at the level of the interatrial septum (IAS) inducing an important thickening of this structure. It...
6.
Rus A, Lazar M, Negrea R, Cozlac A, Vacarescu C, Sosdean R, et al.
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541180
: Acute coronary syndrome (ACS), a prevalent global cardiovascular disease and leading cause of mortality, is significantly correlated with meteorological factors. This study aims to analyze the impact of short-term...
7.
Frisan A, Mornos C, Lazar M, Sosdean R, Crisan S, Ionac I, et al.
Medicina (Kaunas)
. 2024 Feb;
60(2).
PMID: 38399487
Myocardial ischemia caused by coronary artery disease (CAD) and the presence of metabolic abnormalities and microvascular impairments detected in patients with diabetes mellitus (DM) are a common cause of left...
8.
Braescu L, Sturza A, Aburel O, Sosdean R, Muntean D, Luca C, et al.
Medicina (Kaunas)
. 2024 Jan;
60(1).
PMID: 38276055
: This cross-sectional study conducted at the Timișoara Institute of Cardiovascular Diseases, Romania, and the Centre for Translational Research and Systems Medicine from "Victor Babeș" University of Medicine and Pharmacy...
9.
Lazar M, Ionac I, Luca C, Petrescu L, Vacarescu C, Crisan S, et al.
Diagnostics (Basel)
. 2023 Sep;
13(18).
PMID: 37761263
Background: The left ventricular (LV) remodelling process represents the main cause of heart failure after a ST-segment elevation myocardial infarction (STEMI). Speckle-tracking echocardiography (STE) can detect early deformation impairment, while...
10.
Pescariu S, Sosdean R, Mircea M, Ionac A, Pescariu S
Biomedicines
. 2023 May;
11(4).
PMID: 37189821
Heart failure with reduced ejection fraction (HFrEF) is a chronic and debilitating disease, which requires extensive diagnostic and treatment resources in order to achieve an acceptable quality of life for...